Search Results - "Lambie, Anna"

Validation of National Institutes of Health Global Scoring System for Chronic Graft-Versus-Host Disease (GVHD) According to Overall and GVHD-Specific Survival by Moon, Joon Ho, Sohn, Sang Kyun, Lambie, Anna, Ellis, Laura, Hamad, Nada, Uhm, Jieun, Gupta, Vikas, Lipton, Jeffrey H, Messner, Hans A, Kuruvilla, John, Kim, Dennis

“…Abstract A new severity grading system for graft-versus-host disease (GVHD) was established by the National Institutes of Health (NIH) consensus criteria…”
Get full text

Extramedullary Disease at Diagnosis of Acute Myeloid Leukemia Does Not Influence Outcome of Patients Undergoing Allogeneic Hematopoietic Cell Transplant in First Complete Remission by Michelis, Fotios V., Messner, Hans A., Alam, Naheed, Gupta, Vikas, Kim, Dennis Dong Hwan, Kuruvilla, John, Lambie, Anna, Viswabandya, Auro, Lipton, Jeffrey H.

“…Occurrence of extramedullary (EM) disease at diagnosis of acute myeloid leukemia (AML) has been associated with increased risk of relapse and worse outcomes…”
Get full text

Analysis of Impact of Comorbidities Constituting the HCT-CI Score on the Outcome of Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia by Michelis, Fotios V., Messner, Hans A., Alam, Naheed, Gupta, Vikas, Kim, Dennis Dong Hwan, Kuruvilla, John, Lambie, Anna, Viswabandya, Auro, Lipton, Jeffrey H.

“…The Hematopoietic Cell Transplant Co-morbidity Index (HCT-CI, Sorror et al 2005) was developed as a prognostic tool for overall survival (OS) and non-relapse…”
Get full text

Clinical Characteristics, Risk Factors and Outcomes of CMV Disease after Allogeneic Stem Cell Transplantation by Alfraih, Feras, Alam, Naheed, Lambie, Anna, Gupta, Vikas, Kim, Dennis Dong Hwan, Kuruvilla, John, Lipton, Jeffrey H., Seftel, Matthew D., Uhm, Jieun, Loach, David, Messner, Hans A.

“…▪ Introduction: Cytomegalovirus disease (CMV-D) is a major complication following allogeneic hematopoietic stem cell transplant (HSCT). CMV monitoring and…”
Get full text

Multiple CMV Reactivations Are Associated with Lower Risk of Relapse Following Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation by Alfraih, Feras, Alam, Naheed, Gupta, Vikas, Kim, Dennis Dong Hwan, Kuruvilla, John, Lipton, Jeffrey H., Loach, David, Seftel, Matthew D., Uhm, Jieun, Lambie, Anna, Messner, Hans A.

“…Introduction : Cytomegalovirus (CMV) is a major infectious complication following allogeneic hematopoietic stem cell transplantation (HSCT). In this study, we…”
Get full text

Development and Validation of a Prognostic Score Involving Disease Status, Patient Age and Donor Type for Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia by Michelis, Fotios V., Kotchetkov, Rouslan, Azeem, Aamir, Grunwald, Rebecca M., Uhm, Jieun, Alam, Naheed, Lambie, Anna, McGillis, Laura, Loach, David, Gupta, Vikas, Kuruvilla, John, Lipton, Jeffrey H., Kim, Dennis D., Seftel, Matthew D., Messner, Hans A.

“…Allogeneic hematopoietic cell transplantation (HCT) is a curative treatment option for acute myeloid leukemia (AML) when indicated. Numerous pre-transplant…”
Get full text

Incidence of Secondary Malignancies Following Allogeneic Hematopoietic Cell Transplantation: A Single Center Experience by Michelis, Fotios V., Kotchetkov, Rouslan, Grunwald, Rebecca M., Azeem, Aamir, Uhm, Jieun, Alam, Naheed, McGillis, Laura, Lambie, Anna, Loach, David, Gupta, Vikas, Kuruvilla, John, Lipton, Jeffrey H., Kim, Dennis D., Seftel, Matthew D., Messner, Hans A.

“…Late effects occurring post allogeneic hematopoietic cell transplantation (HCT) include the development of secondary malignancies (SM). The purpose of this…”
Get full text

A Risk Score to Predict CMV Viremia within the First 100 Days after Allogeneic Stem Cell Transplantation Based on Pre-Transplant Parameters by Alfraih, Feras, Kuruvilla, John, Alam, Naheed, Lambie, Anna, Gupta, Vikas, Kim, Dennis Dong Hwan, Seftel, Matthew D., Uhm, Jieun, Loach, David, Atenafu, Eshetu G, Lipton, Jeffrey H., Messner, Hans A.

“…▪ Introduction: Cytomegalovirus (CMV) is a major infectious complication following allogeneic hematopoietic stem cell transplantation (HSCT). Risk of CMV…”
Get full text

Evaluation of the Disease Risk Index on Outcomes Following Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes by Michelis, Fotios V., Messner, Hans A., Uhm, Jieun, Alam, Naheed, Loach, David, McGillis, Laura, Lambie, Anna, Gupta, Vikas, Kuruvilla, John, Lipton, Jeffrey H., Seftel, Matthew D., Kim, Dennis D.

“…Allogeneic hematopoietic cell transplantation (HCT) is a curative treatment option when indicated for myeloid malignancies such as acute myeloid leukemia (AML)…”
Get full text

The Modified Pre-Transplant EBMT Risk Score Is Superior To The HCT-CI Score In Predicting Overall Survival and Non-Relapse Mortality After Allogeneic Hematopoietic Cell Transplantation In Patients With Acute Myeloid Leukemia by Michelis, Fotios V., Messner, Hans A., Uhm, Jieun, Lambie, Anna, McGillis, Laura, Gupta, Vikas, Kuruvilla, John, Lipton, Jeffrey H., Hwan Kim, Dennis Dong

“…A variety of factors have been investigated for their influence on outcomes post-allogeneic hematopoietic cell transplantation (HCT). Pre-HCT risk scores have…”
Get full text

A Comparison Of Long-Term Outcomes Of Donor Lymphocyte Infusions and Tyrosine Kinase Inhibitors In CML Patients Relapsed After Allogeneic Hemopoietic Stem Cell Transplantation by Shanavas, Mohamed, Messner, Hans A., Kamel-Reid, Suzanne, Atenafu, Eshetu G, Gupta, Vikas, Kuruvilla, John, Hwan Kim, Dennis Dong, Uhm, Jieun, Lambie, Anna, Ellis, Laura, Lipton, Jeffrey H.

“…Abstract 5501 Relapse is a major cause of treatment failure of allogeneic hematopoietic cell transplantation (HCT) for Chronic Myeloid Leukemia (CML). DLI…”
Get full text

Predictors of the Trajectory of Neurocognitive Functioning in the First Six Months after Allogeneic Hematopoietic Stem Cell Transplantation by Mayo, Samantha J, Messner, Hans A., Rourke, Sean B., Howell, Doris, Victor, J. Charles, Kuruvilla, John, Lipton, Jeffrey H., Gupta, Vikas, Kim, Dennis Dong Hwan, McGillis, Laura, Uhm, Jieun, Michelis, Fotios V., Alam, Naheed, Lambie, Anna, Breen, Dawn, Loach, David, Piescic, Christine, Metcalfe, Kelly

“…Background: While most patients will not experience lasting neurocognitive effects from stem cell transplant, certain subgroups of patients may be particularly…”
Get full text

CMV Reactivations and Their Impact On Outcomes in Patients After Hematopoietic Cell Transplantation by Alam, Naheed, Lambie, Anna, Yunes, Yvette Neme, Alfraih, Feras, Atenafu, Eshetu G, Kim, Dennis Dong Hwan, Gupta, Vikas, Kuruvilla, John, Lipton, Jeff H, Messner, Hans A.

“…Abstract 4501 CMV (Cytomegalovirus) reactivations are a major cause of morbidity and mortality in recipients of hematopoietic cell transplantation (HCT). Risk…”
Get full text

Modified EBMT Pretransplant Risk Score Can Identify Favorable-risk Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for AML, Not Identified by the HCT-CI Score by Michelis, Fotios V, Messner, Hans A, Uhm, Jieun, Alam, Naheed, Lambie, Anna, McGillis, Laura, Seftel, Matthew D, Gupta, Vikas, Kuruvilla, John, Lipton, Jeffrey H, Kim, Dennis (Dong Hwan)

“…Micro-Abstract We investigated the influence of the mEBMT and HCT-CI pre-transplant risk scores on 350 patients undergoing allogeneic transplant for acute…”
Get full text

A Comparison of Long-Term Outcomes of Donor Lymphocyte Infusions and Tyrosine Kinase Inhibitors in Patients With Relapsed CML After Allogeneic Hematopoietic Cell Transplantation by Shanavas, Mohamed, Messner, Hans A, Kamel-Reid, Suzanne, Atenafu, Eshetu G, Gupta, Vikas, Kuruvilla, John, Kim, Dennis (Dong Hwan), Uhm, Jieun, Lambie, Anna, Ellis, Laura, Lipton, Jeffrey H

“…Micro-Abstract We retrospectively analyzed the long-term outcomes in 46 patients who received donor lymphocyte infusion (DLI) or tyrosine kinase inhibitors…”
Get full text

Molecular relapse after allogeneic hematopoietic cell transplant for chronic myeloid leukemia: some long-term survivors appear to tolerate even lack of major molecular response by Shanavas, Mohamed, Messner, Hans A., Kamel-Reid, Suzanne, Atenafu, Eshetu G., Gupta, Vikas, Kuruvilla, John, Kim, Dennis (Dong Hwan), Uhm, Jieun, Lambie, Anna, Ellis, Laura, Lipton, Jeffrey H.

Get full text